日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Alirocumab plus cemiplimab in advanced immuno-refractory metastatic non-small cell lung cancer: an ongoing multi-center phase II study

Alirocumab联合cemiplimab治疗晚期免疫难治性转移性非小细胞肺癌:一项正在进行的多中心II期研究

Oduah, Eziafa I; Zhang, Tian; Jung, Sin-Ho; Stinchcombe, Thomas E; Ready, Neal; Crawford, Jeffrey; Clarke, Jeffrey M; Gray, Jhanelle E; Antonia, Scott J

Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.

针对补体因子 H 的抗体 GT103 在难治性非小细胞肺癌中的应用:一项 1b 期剂量递增试验

Clarke Jeffrey M, Simon George R, Mamdani Hirva, Gu Lin, Herndon James E 2nd, Stinchcombe Thomas E, Ready Neal, Crawford Jeffrey, Sonpavde Guru, Balevic Stephen, Nixon Andrew B, Campa Michael, Gottlin Elizabeth B, Li Huihua, Saxena Ruchi, He You Wen, Antonia Scott, Patz Edward F Jr

Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis

早期非小细胞肺癌(NSCLC)围手术期帕博利珠单抗治疗:安全性、有效性和探索性生物标志物分析

Wood, Cameron; Lyniv, Liliana; Isaacs, James M; Kaufman, Jacob M; Oduah, Eziafa I; Clarke, Jeff; Crawford, Jeffrey; Stinchcombe, Thomas; Tong, Betty C; Wang, Xiaofei; Gu, Lin; Wigle, Dennis; Dragnev, Konstantin H; Antonia, Scott J; Weinhold, Kent; Ready, Neal

A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck

一项分两阶段进行的 II 期多中心随机双盲安慰剂对照研究,旨在评估 EC-18 在改善头颈部鳞状细胞癌放化疗继发性口腔黏膜炎的严重程度和病程方面的安全性和有效性。

Henson, Christina; Clayburgh, Daniel; Lee, Arielle; Wong, Deborah; Kudrimoti, Mahesh; Lee, Steve; Kalman, Noah; Rao, Krishna; Sohn, Ki Young; Crawford, Jeffrey; Villa, Alessandro; Sonis, Stephen

A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia

一项 Ib 期首次人体研究,旨在评估 Ponsegromab 在癌症合并恶病质患者中的安全性、耐受性、药代动力学和药效学。

Crawford, Jeffrey; Calle, Roberto A; Collins, Susie M; Weng, Yan; Lubaczewski, Shannon L; Buckeridge, Clare; Wang, Ellen Q; Harrington, Magdalena A; Tarachandani, Anil; Rossulek, Michelle I; Revkin, James H

Mortality burden of pre-treatment weight loss in patients with non-small-cell lung cancer: A systematic literature review and meta-analysis

非小细胞肺癌患者治疗前体重减轻的死亡负担:系统文献综述和荟萃分析

Bonomi, Philip D; Crawford, Jeffrey; Dunne, Richard F; Roeland, Eric J; Smoyer, Karen E; Siddiqui, Mohd Kashif; McRae, Thomas D; Rossulek, Michelle I; Revkin, James H; Tarasenko, Lisa C

The mortality burden of cachexia or weight loss in patients with colorectal or pancreatic cancer: A systematic literature review

结直肠癌或胰腺癌患者恶病质或体重减轻的死亡负担:系统性文献综述

Dunne, Richard F; Crawford, Jeffrey; Smoyer, Karen E; McRae, Thomas D; Rossulek, Michelle I; Revkin, James H; Tarasenko, Lisa C; Bonomi, Philip D

Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design

一项评估ponsegromab治疗癌症恶病质患者疗效和安全性的II期研究:PROACC-1研究设计

Groarke, John D; Crawford, Jeffrey; Collins, Susie M; Lubaczewski, Shannon L; Breen, Danna M; Harrington, Magdalena A; Jacobs, Ira; Qiu, Ruolun; Revkin, James; Rossulek, Michelle I; Saxena, Aditi R

The impact of myelosuppression on quality of life of patients treated with chemotherapy

骨髓抑制对接受化疗患者生活质量的影响

Crawford, Jeffrey; Herndon, Dana; Gmitter, Katerina; Weiss, Jared

Aire mediates tolerance to insulin through thymic trimming of high-affinity T cell clones

Aire 通过胸腺修剪高亲和力 T 细胞克隆来介导对胰岛素的耐受性

Jennifer A Smith #, Benjamin T K Yuen #, Whitney Purtha, Jared M Balolong, Jonah D Phipps, Frances Crawford, Jeffrey A Bluestone, John W Kappler, Mark S Anderson